Zimmer Biomet Exceeds Expectations with Second Quarter Performance

Zimmer Biomet reported 2Q22 orthopedic sales of $1.8 billion, +1% vs. 2Q21. The company exceeded its internal expectations for the quarter, citing COVID recovery and execution across the company's regions and segments.

Against weaker comparisons from 2Q21, Zimmer Biomet drove double-digit growth in markets outside the U.S. despite COVID...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us